2,331
Views
16
CrossRef citations to date
0
Altmetric
Research Paper

HPV vaccination acceptability among men who have sex with men in Urumqi, China

ORCID Icon, , , , , , , , & show all
Pages 1005-1012 | Received 05 May 2018, Accepted 01 Sep 2018, Published online: 25 Sep 2018

References

  • Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. Rev Med Virol. 2015;25(Suppl 1):2–23. doi:10.1002/rmv.1822.
  • Machalek DA, Grulich AE, Jin FY, Templeton DJ, Poynten IM. The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health. 2012;9:527–537. doi:10.1071/SH12043.
  • Machalek DA, Poynten M, Jin FY, Fairley CK, Farnsworth A, Garland SM, Hillman RJ, Petoumenos K, Roberts J, Tabrizi SN, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012;13:487–500. doi:10.1016/S1470-2045(12)70080-3.
  • Giuliano AR, Anic G, Nyitray AG. Epidemiology and pathology of HPV disease in males. Gynecol Oncol. 2010;117:S15–9. doi:10.1016/j.ygyno.2010.01.026.
  • De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S. Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: A meta-analysis. Int J Cancer. 2009;124:1626–1636. doi:10.1002/ijc.24116.
  • Tian T, Mijiti P, Huang BX, Zhang FD, Ainiwaer A, Sang GY, Zhang ZL, Mahan Y, Tuo XQ, Gong Z, et al. Prevalence and risk factors of anal human papillomavirus infection among HIV-negative men who have sex with men in Urumqi city of Xinjiang Uyghur Autonomous Region, China. Plos One. 2017;12. doi:10.1371/journal.pone.0187928.
  • Gao L, Zhou F, Li XW, Yang Y, Ruan YH, Anal JQ. HPV infection in HIV-positive men who have sex with men from China. Plos One. 2010;5. doi:10.1371/journal.pone.0015256.
  • Zhang DY, Yin YP, Feng TJ, Hong FC, Jiang N, Wang BX, Chen XS. HPV Infections among MSM in Shenzhen, China. Plos One. 2014;9. doi:10.1371/journal.pone.0096364.
  • Li XW, Li MF, Yang Y, Zhong X, Feng BX, Xin HA, Li Z, Jin Q, Gao L. Anal HPV/HIV co-infection among men who have sex with men: a cross-sectional survey from three cities in China. Sci Rep-Uk. 2016;6. doi:10.1038/srep21368.
  • Llata E, Stenger M, Bernstein K, Guerry S, Kerani R, Pugsley R, Pathela P, Tabidze I, Weinstock H; Grp SGW. Prevalence of genital warts among sexually transmitted disease clinic patients-sexually transmitted disease surveillance network, United States, January 2010 to December 2011. Sex Transm Dis. 2014;41:89–93. doi:10.1097/OLQ.0000000000000077.
  • Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine. 2006;24(Suppl 3):S3/35–41. doi:10.1016/j.vaccine.2006.06.015.
  • Chaturvedi AK. Beyond cervical cancer: burden of other HPV-related cancers among men and women. J Adolescent Health. 2010;46:S20–S26. doi:10.1016/j.jadohealth.2010.01.016.
  • Human papillomavirus vaccines: WHO position paper, May 2017. Releve epidemiologique hebdomadaire. World Health Organization 2017;92:241–268. doi:10.1016/j.vaccine.2017.05.069.
  • Schiller JT, Castellsague X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012;30:F123–F138. doi:10.1016/j.vaccine.2012.04.108.
  • Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, Vardas E, Moi H, Jessen H, Hillman R, et al. Efficacy of quadrivalent HPV vaccine against HPV infection and disease in males. New Engl J Med. 2011;364:401–411. doi:10.1056/NEJMoa0909537.
  • Yancey AM, Pitlick JM, Forinash AB. The prophylactic role for the human papillomavirus quadrivalent vaccine in males. Ann Pharmacother. 2010;44:1314–1318. doi:10.1345/aph.1P017.
  • Zou H, Zhang L, Puifung CE, Zhang L. Teenage men who have sex with men should be vaccinated against human papillomavirus infection. Zhonghua liu xing bing xue za zhi. 2014;35:1072–1073.
  • Ali H, Donovan B, Wand H, Read TRH, Regan DG, Grulich AE, Fairley CK, Guy RJ. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. Bmj-Brit Med J. 2013;346. doi:10.1136/bmj.f2032.
  • Kim JJ. Targeted human papillomavirus vaccination of men who have sex with men in the USA: a cost-effectiveness modelling analysis. Lancet Infect Dis. 2010;10:845–852. doi:10.1016/S1473-3099(10)70219-X.
  • Fenkl EA, Jones SG, Schochet E, Johnson P. HPV and anal cancer knowledge among HIV-infected and non-infected men who have sex with men. Lgbt Health. 2016;3:42–48. doi:10.1089/lgbt.2015.0086.
  • Lau JT, Wang Z, Kim JH, Lau M, Lai CH, Mo PK. Acceptability of HPV vaccines and associations with perceptions related to HPV and HPV vaccines among men who have sex with men in Hong Kong. Plos One. 2013;8:e57204. doi:10.1371/journal.pone.0057204.
  • Nadarzynski T, Smith H, Richardson D, Jones CJ, Llewellyn CD. Human papillomavirus and vaccine-related perceptions among men who have sex with men: a systematic review. Sex Transm Infect. 2014;90:515–523. doi:10.1136/sextrans-2013-051357.
  • Perlman S, Wamai RG, Bain PA, Welty T, Welty E, Ogembo JG. Knowledge and awareness of HPV vaccine and acceptability to vaccinate in sub-Saharan Africa: a systematic review. Plos One. 2014;9:e90912. doi:10.1371/journal.pone.0090912.
  • Wang Z, Mo PK, Lau JT, Lau M, Lai CH. Acceptability of HPV vaccines and perceptions related to genital warts and penile/anal cancers among men who have sex with men in Hong Kong. Vaccine. 2013;31:4675–4681. doi:10.1016/j.vaccine.2013.06.090.
  • Zou H, Meng X, Jia T, Zhu C, Chen X, Li X, Xu J, Ma W, Zhang X. Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study. Hum Vaccin Immunother. 2016;12:1551–1559. doi:10.1080/21645515.2015.1099771.
  • Reiter PL, Brewer NT, Mcree AL, Gilbert P, Smith JS. Acceptability of HPV vaccine among a national sample of gay and bisexual men. Sex Transm Dis. 2010;37:197–203. doi:10.1097/OLQ.0b013e3181bf542c.
  • Dona MG, Palamara G, Di Carlo A, Latini A, Vocaturo A, Benevolo M, Pimpinelli F, Giglio A, Moretto D, Impara G, et al. Prevalence, genotype diversity and determinants of anal HPV infection in HIV-uninfected men having sex with men. J Clin Virol. 2012;54:185–189. doi:10.1016/j.jcv.2012.02.014.
  • Liu J, Qu B,CEM, Zhang Y, Liang S. Factors associated with HIV infection among men who have sex with men in Henan Province, China: a cross-sectional study. BMC Public Health. 2013;13:356. doi:10.1186/1471-2458-13-356.
  • Sadlier C, Lynam A, O’Dea S, Delamere S, Quinlan M, Clarke S, Sheils O, Bergin C. HPV vaccine acceptability in HIV-infected and HIV negative men who have sex with men (MSM) in Ireland. Hum Vacc Immunother. 2016;12:1536–1541. doi:10.1080/21645515.2016.1151588.
  • Wang Z, Wang L, Jing J, Hu C. Prevalence of mental disorders in migrants compared with original residents and local residents in Ningxia, China. BMC Psychiatry. 2016;16:366. doi:10.1186/s12888-016-1088-y.
  • Zou X, Chow EP, Zhao P, Xu Y, Ling L, Zhang L. Rural-to-urban migrants are at high risk of sexually transmitted and viral hepatitis infections in China: a systematic review and meta-analysis. BMC Infect Dis. 2014;14:490. doi:10.1186/1471-2334-14-490.
  • Zou HC, Meng XJ, Jia TJ, Zhu C, Chen X, Li XL, Xu JJ, Ma W, Zhang X. Awareness and acceptance of human papillomavirus (HPV) vaccination among males attending a major sexual health clinic in Wuxi, China: A cross-sectional study. Hum Vacc Immunother. 2016;12:1551–1559. doi:10.1080/21645515.2015.1099771.
  • Simatherai D, Bradshaw CS, Fairley CK, Bush M, Heley S, Chen MY. What men who have sex with men think about the human papillomavirus vaccine. Sex Transm Infect. 2009;85:148–149. doi:10.1136/sti.2008.032581.
  • Sundstrom K, Tran TN, Lundholm C, Young C, Sparen P, Dahlstrom LA. Acceptability of HPV vaccination among young adults aged 18-30 years–a population based survey in Sweden. Vaccine. 2010;28:7492–7500. doi:10.1016/j.vaccine.2010.09.007.
  • Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine. 2010;28:4027–4037. doi:10.1016/j.vaccine.2010.03.063.
  • Brewer NT, Chapman GB, Gibbons FX, Gerrard M, McCaul KD, Weinstein ND. Meta-analysis of the relationship between risk perception and health behavior: the example of vaccination. Health Psychol. 2007;26:136–145. doi:10.1037/0278-6133.26.2.136.
  • Chaparro RM, Em Vargas V, Zorzo LR, Genero S, Cayre A. Acceptance of human papillomavirus vaccination and associated factors in the city of Resistencia, Argentina. Arch Argent Pediatr. 2016;114:36–43. doi:10.5546/aap.2016.eng.36.
  • Toft L, Storgaard M, Muller M, Sehr P, Bonde J, Tolstrup M, Ostergaard L, Sogaard OS. Comparison of the immunogenicity and reactogenicity of Cervarix and Gardasil human papillomavirus vaccines in HIV-infected adults: a randomized, double-blind clinical trial. J Infect Dis. 2014;209:1165–1173. doi:10.1093/infdis/jit657.
  • Rank C, Gilbert M, Ogilvie G, Jayaraman GC, Marchand R, Trussler T, Hogg RS, Gustafson R, Wong T. Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: implications for targeted vaccination programs. Vaccine. 2012;30:5755–5760. doi:10.1016/j.vaccine.2012.07.001.
  • Goldstone S. Efficacy of the quadrivalent Hpv vaccine to prevent anal intraepithelial neoplasia among young men who have sex with men. Sex Transm Infect. 2011;87:A352–A352. doi:10.1128/CVI.05208-11.